Concepedia

Sharon Friedman-Urevich

SF

3

Publications

37

Citations

3

H-Index

2006

Active since

Affiliations

Winthrop-University Hospital(Current)

Sharon Friedman-Urevich is an author at Winthrop-University Hospital specializing in cell transplantation, clinical trials, and multiple sclerosis.

Top concepts

Publications per year

2006–2019

3

Publications

3

Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate

Stephen Farley, Malcolm Gottesman, Sharon Friedman-Urevich et al. · Surgical Neurology International · 2019 · 16 citations · Full text

High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis: 2-Year Follow-up (Investigational New Drug No. 65863)

Douglas E. Gladstone, Robert G. Peyster, E. Baron et al. · American Journal of Therapeutics · 2010 · 11 citations

, , +21

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)

M H Gottesman, Sharon Friedman-Urevich · Multiple Sclerosis Journal · 2006 · 10 citations

Rows per page

1–3 of 3